摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloro-N-methylthiazole-5-carboxamide | 928256-36-4

中文名称
——
中文别名
——
英文名称
2-chloro-N-methylthiazole-5-carboxamide
英文别名
2-Chloro-N-methyl-5-thiazolecarboxamide;2-chloro-N-methyl-1,3-thiazole-5-carboxamide
2-chloro-N-methylthiazole-5-carboxamide化学式
CAS
928256-36-4
化学式
C5H5ClN2OS
mdl
——
分子量
176.626
InChiKey
JXTJLLQAOBWFLL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    70.2
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • BENZOTHIAZOLE AND BENZOOXAZOLE DERIVATIVES AND METHODS OF USE
    申请人:Black Lawrence A.
    公开号:US20090163464A1
    公开(公告)日:2009-06-25
    Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions of compounds of formula (I), methods for using such compounds and compositions, and a process for preparing the compounds.
    式(I)的化合物在治疗受组织胺-3受体配体预防或改善的症状或疾病方面具有用处。还公开了式(I)的化合物的药物组合物、使用这种化合物和组合物的方法,以及制备这些化合物的过程。
  • Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders
    申请人:Yamashita Hiroshi
    公开号:US20090264404A1
    公开(公告)日:2009-10-22
    A heterocyclic compound or a salt thereof represented by the formula (1): where R 2 represents a hydrogen atom or a lower alkyl group; A represents a lower alkylene group or lower alkenylene group; and R 1 represents an aromatic group or a heterocyclic group. The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.
    一种杂环化合物或其盐,其化学式为(1):其中R2代表氢原子或较低的烷基基团;A代表较低的烷基烯基基团;R1代表芳香族基团或杂环基团。本发明的化合物具有广泛的治疗精神障碍的谱,包括中枢神经系统障碍,无副作用且安全性高。
  • DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZO[B]THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS
    申请人:YAMASHITA Hiroshi
    公开号:US20120028920A1
    公开(公告)日:2012-02-02
    A heterocyclic compound or a salt thereof represented by the formula (1): where R 2 represents a hydrogen atom or a lower alkyl group; A represents a lower alkylene group or lower alkenylene group; and R 1 represents an aromatic group or a heterocyclic group. The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.
    一种由式(1)所表示的杂环化合物或其盐:其中R2代表氢原子或较低的烷基基团;A代表较低的烷基烯基基团;R1代表芳香基团或杂环基团。本发明的化合物具有广泛的治疗精神障碍的光谱,包括中枢神经系统障碍,无副作用且安全性高。
  • HETEROCYCLIC COMPOUND
    申请人:OTSUKA PHARMACEUTICAL CO., LTD.
    公开号:EP1919907B1
    公开(公告)日:2011-02-23
  • Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders
    申请人:Otsuka Pharmaceutical Co., Limited
    公开号:EP2284169B1
    公开(公告)日:2012-03-14
查看更多